Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05600738 · ClinicalTrials.gov registry record · NA
Network Effects of Therapeutic Deep Brain Stimulation
A NA study of Intractable Epilepsy, sponsored by The University of Texas Health Science Center, Houston.
- Recruiting
- Registry status
- NA
- Development phase
- 25
- Enrollment target
- 1
- Study location
NCT05600738: Recruiting NA study of Intractable Epilepsy, sponsored by The University of Texas Health Science Center, Houston.
NCT05600738 is a NA study of Intractable Epilepsy that is actively recruiting participants, run by The University of Texas Health Science Center, Houston. The registered enrollment target is 25 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05600738, a NA study of Intractable Epilepsy, is actively recruiting participants, sponsored by The University of Texas Health Science Center, Houston.
- RECRUITING
- Registry status
- NA
- Development phase
- 25 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to map the acute, short-term cortical evoked responses to thalamic electrical stimulation in persons with intractable epilepsy
Conditions Studied
Interventions
- DEVICE RNS/DBS activation
Study Locations (1)
Texas
- The University of Texas Health Science Center at Houston - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2022-08-26 |
| Est. Completion | 2027-12-31 |
| Phase | NA |
What NCT05600738 shows while recruiting
NCT05600738 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 25 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 1 condition, with Intractable Epilepsy appearing as the primary indexed condition, and to 1 intervention - of which RNS/DBS activation is the first listed.
NCT05600738 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT05600738 about?
NCT05600738 is a clinical study titled "Network Effects of Therapeutic Deep Brain Stimulation". The purpose of this study is to map the acute, short-term cortical evoked responses to thalamic electrical stimulation in persons with intractable epilepsy
What is the current status of trial NCT05600738?
This trial is currently recruiting. It is a NA study. The enrollment target is 25 participants. The study started on 2022-08-26. Estimated completion is 2027-12-31.
What conditions does trial NCT05600738 study?
This clinical trial studies the following conditions: Intractable Epilepsy.
What interventions are being tested in trial NCT05600738?
The interventions under investigation include: RNS/DBS activation (DEVICE).
Who is sponsoring clinical trial NCT05600738?
This trial is sponsored by The University of Texas Health Science Center, Houston, which has 732 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05600738 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Intractable Epilepsy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05600738's enrollment target sits among peer trials
25 1712th of 2000 higher than 265 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01166854 · 25 participants
Characterization of Familial Myopathy and Paget Disease of Bone
- NCT01913106 · 25 participants · Phase 1
HSV-tk + Valacyclovir Therapy in Combination With Brachytherapy for Recurrent Prostate Cancer
- NCT02138669 · 25 participants · NA
Intacs Prescription Inserts for Keratoconus Patients
- NCT02174549 · 25 participants · Phase 1
Dose-defining Study of Tirapazamine Combined With Embolization in Liver Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI